Literature DB >> 3088464

Effect of chronic valproate treatment on folate-dependent methyl biosynthesis in the rat.

G F Carl.   

Abstract

Folate deficiency has been associated with chronic anticonvulsant therapy. Characterization of the effects of individual anticonvulsants has been undertaken. Chronic treatment of rats with sodium valproate caused a decrease in liver folate concentration with concomitant increases in brain and plasma folate concentrations. After several weeks, these trends were reversed and folate concentrations tended to normalize. Chronic valproate treatment affected the activities of folate-dependent one-carbon enzymes: Serine hydroxymethyltransferase activity in liver was increased; methylenetetrahydrofolate reductase activity in both brain and liver was decreased; and methyltetrahydrofolate:homocysteine methyltransferase activity in both brain and liver decreased initially but returned toward normal with continued treatment. Methionine adenosyltransferase activity in brain declined after several weeks of treatment but the concentration of S-adenosylmethionine in liver increased with chronic valproate treatment. These data are consistent with the hypothesis that the effects of anticonvulsants on folates are a consequence of the mechanism of action of the anticonvulsant.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3088464     DOI: 10.1007/bf00965336

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  33 in total

1.  Reversible dementia due to folate deficiency.

Authors:  J D Sapira; S Tullis; R Mullaly
Journal:  South Med J       Date:  1975-06       Impact factor: 0.954

2.  Evaluation of folic acid supplements in children taking phenytoin.

Authors:  J C Bowe; E J Cornish; M Dawson
Journal:  Dev Med Child Neurol       Date:  1971-06       Impact factor: 5.449

3.  A controlled study of folic acid in epilepsy. A controlled study of folic acid in epilepsy.

Authors:  J W Norris; R F Pratt
Journal:  Neurology       Date:  1971-06       Impact factor: 9.910

4.  Methionine adenosyltransferase. A double-isotope derivative, enzymatic assay.

Authors:  S Matthysse; R J Baldessarini; M Vogt
Journal:  Anal Biochem       Date:  1972-08       Impact factor: 3.365

5.  Radioenzymatic estimation of S-adenosylmethionine in rat brain regions and subcellular fractions.

Authors:  P H Yu
Journal:  Anal Biochem       Date:  1978-06-01       Impact factor: 3.365

6.  Effect of chronic phenobarbital treatment on folates and one-carbon enzymes in the rat.

Authors:  G F Carl; D B Smith
Journal:  Biochem Pharmacol       Date:  1984-11-01       Impact factor: 5.858

7.  Interaction of phenytoin and folate in the rat.

Authors:  G F Carl; D B Smith
Journal:  Epilepsia       Date:  1983-08       Impact factor: 5.864

8.  Dipropylacetate and aminoaciduria.

Authors:  S Similä; L von Wendt; S L Linna
Journal:  J Neurol Sci       Date:  1980-02       Impact factor: 3.181

Review 9.  Phospholipid methylation and biological signal transmission.

Authors:  F Hirata; J Axelrod
Journal:  Science       Date:  1980-09-05       Impact factor: 47.728

10.  Effect of chronic primidone treatment on folate-dependent one-carbon metabolism in the rat.

Authors:  G F Carl; M W Gill; R A Schatz
Journal:  Biochem Pharmacol       Date:  1987-07-01       Impact factor: 5.858

View more
  3 in total

1.  Effect of maternal exposure to homocystine on sodium valproate-induced neural tube defects in the mouse embryos.

Authors:  R Padmanabhan; M Shafiullah; S Benedict; N Nagelkerke
Journal:  Eur J Nutr       Date:  2006-05-13       Impact factor: 5.614

2.  The effect of GABA receptor ligands in experimental spina bifida occulta.

Authors:  W Briner
Journal:  BMC Pharmacol       Date:  2001-08-15

3.  Methylation of migraine-related genes in different tissues of the rat.

Authors:  Sieneke Labruijere; Lisette Stolk; Michael Verbiest; René de Vries; Ingrid M Garrelds; Paul H C Eilers; A H Jan Danser; André G Uitterlinden; Antoinette MaassenVanDenBrink
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.